Skye Bioscience, Inc. SEC filings SKYE
Skye Bioscience, Inc. has 631 filings in SEC EDGAR's recent list, going back to Mar 25, 2011. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 11, 2026 (agreement ended, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRER14A | Filing | Oct 28, 2026 | — |
| PREM14A | Filing | Oct 26, 2026 | Oct 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 14, 2026 | — |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 24, 2026 | — |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 16, 2026 |
| 4 | Insider transaction | Sep 18, 2026 | Sep 16, 2026 |
| DEFA14A | Additional proxy material | Sep 11, 2026 | — |
| 8-K |
Current report
Agreement ended, Officer or director change, Other events
|
Sep 11, 2026 | Sep 8, 2026 |
| DEFA14A | Additional proxy material | Aug 24, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 24, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| 4 | Insider transaction | Aug 20, 2026 | Aug 18, 2026 |
| DEFA14A | Additional proxy material | Aug 20, 2026 | — |
| 8-K/A |
Amended current report
Change to shareholder rights
|
Aug 20, 2026 | Aug 12, 2026 |
| DEFA14A | Additional proxy material | Aug 19, 2026 | — |
| 8-K |
Current report
Listing notice
|
Aug 19, 2026 | Aug 18, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 18, 2026 | — |
| DEFA14A | Additional proxy material | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 7, 2026 |
| 8-K |
Current report
Other events
|
Jun 23, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 29, 2026 | May 26, 2026 |
| 8-K |
Current report
Listing notice
|
May 15, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 3 | Initial insider ownership | Apr 28, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 26, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2026 | Apr 6, 2026 |
| PREM14A | Def 14a | Apr 6, 2026 | Apr 6, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 3/A | Form 3/a | Apr 2, 2026 | Mar 4, 2024 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 19, 2026 | Mar 17, 2026 |
| S-8 | Employee stock plan registration | Mar 11, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 20, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2025 | Dec 18, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 16, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 6, 2025 | Oct 6, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 21, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Auditor change, Shareholder vote results
|
Jun 11, 2025 | Jun 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 3 | Initial insider ownership | Apr 25, 2025 | Apr 23, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Apr 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 10, 2025 | — |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 4/A | Form 4/a | Feb 28, 2025 | Nov 15, 2024 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2025 | Feb 24, 2025 |
| UPLOAD | Letter from the SEC | Feb 5, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2024 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 19, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2024 | — |
| 4 | Insider transaction | Nov 20, 2024 | Nov 15, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| S-8 | Employee stock plan registration | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 29, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 24, 2024 | Oct 22, 2024 |
| DEF 14A | Proxy statement | Sep 23, 2024 | Sep 23, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 11, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Sep 13, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 4, 2024 | Sep 3, 2024 |
| 3 | Initial insider ownership | Sep 4, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 26, 2024 |
| SC 13G | Ownership over 5% (passive) | Aug 14, 2024 | — |
| S-8 | Employee stock plan registration | Aug 12, 2024 | — |
| S-8 | Employee stock plan registration | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 5, 2024 | Jul 2, 2024 |
| 3 | Initial insider ownership | Jul 5, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 3, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Other events
|
Jun 10, 2024 | Jun 10, 2024 |
| EFFECT | Filing | May 17, 2024 | — |
| EFFECT | Filing | May 17, 2024 | — |
| 424B3 | Prospectus | May 17, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| CORRESP | Letter to the SEC | May 15, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| UPLOAD | Letter from the SEC | May 14, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| S-3 | Shelf registration | May 10, 2024 | — |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| EFFECT | Filing | Apr 26, 2024 | — |
| POS AM | Filing | Apr 24, 2024 | — |
| EFFECT | Filing | Apr 10, 2024 | — |
| 424B3 | Prospectus | Apr 10, 2024 | — |
| CERT | Filing | Apr 10, 2024 | — |
| 8-A12B | Filing | Apr 10, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| CORRESP | Letter to the SEC | Apr 9, 2024 | — |
| S-1/A | Amended registration statement | Apr 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 3, 2024 | Apr 3, 2024 |
| UPLOAD | Letter from the SEC | Apr 2, 2024 | — |
| S-1 | Registration statement | Mar 27, 2024 | — |
| D | Filing | Mar 27, 2024 | — |
| 10-K | Annual report | Mar 22, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 13, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 13, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 13, 2024 | Mar 11, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 4, 2024 | Feb 29, 2024 |
| 3 | Initial insider ownership | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 3 | Initial insider ownership | Mar 4, 2024 | Feb 29, 2024 |
| 4/A | Form 4/a | Mar 4, 2024 | Feb 29, 2024 |
| 4/A | Form 4/a | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 1, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Other events
|
Feb 12, 2024 | Feb 12, 2024 |
| D | Filing | Feb 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 5, 2024 | — |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 31, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 29, 2024 | Jan 29, 2024 |
| S-8 | Employee stock plan registration | Dec 22, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 5, 2023 | Nov 29, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 7, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Nov 6, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Nov 6, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Nov 6, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Nov 6, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Nov 6, 2023 | Nov 6, 2023 |
| 4 | Insider transaction | Nov 6, 2023 | Nov 6, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SKYE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1516551
- Former names
- Emerald Bioscience, Inc. (until Jan 7, 2021); Nemus Bioscience, Inc. (until Mar 14, 2019); LOAD GUARD LOGISTICS, INC. (until Oct 30, 2014); LOAD GUARD TRANSPORTATION, INC. (until Nov 7, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.